None listed
Conditions
Interventions
None listed
Sponsors
The Himalaya Drug Company Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Young Healthy Adolescent male and female subjects. Aged between >=18 years to Subjects who can refrain or who are not on any other supplements for constipation Subjects willing to sign informed consent and follow the study procedure. Has not participated in any clinical study in the last one month.
Exclusion criteria
Exclusion criteria: Subjects with any clinical significant systemic illness. A known history or present condition of allergic response to products its components or to any of the ingredients in the test product Pre-existing systemic disease requiring long-term medications. Subjects treated with any laxatives 2 weeks prior to screening and are experiencing the laxative effect. Pregnant & nursing women.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| To assess overall compliance to the study interventionTimepoint: DAY 5 and DAY 7 | — |
Primary
| Measure | Time frame |
|---|---|
| Normal values of all Laboratory parameters assessed before and after the intervention. To assess any Adverse events reported or observed during the study periodTimepoint: Screening/Day 1, Day 5 Day 7 | — |
Countries
India
Contacts
Public ContactDr Srikrishna H A
The Himalaya Drug Company Ltd
Outcome results
None listed